<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for Calendar Year or Quarter Ended: March 31, 2000
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings
entries.
Institutional Investment Manager Filing this Report:
Name: BB Biotech AG
Address: Vordergasse 3
Grafenauweg 4
Zug, Switzerland CH-6301
Form 13F File Number: 28-6964
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables are considered integral parts of this form. Person
Signing this Report on Behalf of Reporting Manager:
Name: Dubravka Racnjak
Title: SIGNING AUTHORITY
------------------
Phone: (41-41) 724-5959
Signature, Place, and Date of Signing:
/s/ Dubravka Racnjak Zug, Switzerland May 5, 2000
<PAGE> 2
Report Type (Check only one.):
[ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported
by other reporting manager(s).)
List of Other Managers Reporting for this Manager:
Name
Biotech Focus S.A.
Biotech Invest S.A.
Biotech Target S.A.
<PAGE> 3
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 3
Form 13F Information Table Entry Total: 21
Form 13F Information Table Value Total: $2,175,027
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Name
1 Biotech Focus S.A.
2 Biotech Invest S.A.
3 Biotech Target S.A.
<PAGE> 4
BB BIOTECH AG
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN 8:
COLUMN 5: VOTING AUTHORITY
COLUMN 4: COLUMN 6:
COLUMN 1: COLUMN 2: COLUMN 3: VALUE ------------------------ INVESTMENT COLUMN 7: ---------------------------
NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/ DISCRETION OTHER
PRN AMT PRN CALL MANAGERS
SOLE SHARED NONE
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Alexion
Pharmaceuticals,
Inc. Common Stock 01535110 $ 127,232 1,824,113 SH DEFINED 3 1,824,113 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Algos
Pharmaceuticals,
Inc. Common Stock 01586910 $ 20,844 1,449,500 SH DEFINED 3 1,449,500 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Alza
Corporation Common Stock 022615108 $ 45,019 1,300,000 SH DEFINED 1 1,300,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Amgen Inc. Common Stock 00075886F1 $ 45,352 690,000 SH DEFINED 1 690,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Aurora
Biosciences,
Inc. Common Stock 05192010 $ 45,234 1,106,500 SH DEFINED 3 1,256,500 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Aviron Common Stock 05376210 $ 73,844 2,655,286 SH DEFINED 2 2,655,286 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Biogen Inc. Common Stock 090597105 $ 61,669 882,500 SH DEFINED 1 882,500 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
CV
Therapeutics,
Inc. Common Stock 12666710 $ 98,857 1,969,647 SH DEFINED 3 1,969,647 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Celgene Corp. Common Stock 151020104 $ 49,780 500,000 SH DEFINED 2 500,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Diversa Corp. Common Stock 255064107 $ 6,625 250,000 SH DEFINED 3 250,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Genentech Common Stock 368710406 $ 162,138 1,066,697 SH DEFINED 1 161,200 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
IDEC
Pharmaceuticals Common Stock 449370105 $ 175,769 1,789,000 SH DEFINED 1 1,789,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Imclone Common Stock 45245W109 $ 66,501 865,000 SH DEFINED 2 865,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Immunex Corp. Common Stock 452528102 $ 116,476 1,836,000 SH DEFINED 1 1,836,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
La Jolla
Pharmaceutical
Company Common Stock 50345910 $ 13,127 2,001,000 SH DEFINED 3 2,001,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
MedImmune Common Stock 58469910 $ 726,993 4,175,000 SH DEFINED 1 4,075,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Neurocrine
Biosciences Common Stock 64125C109 $ 20,693 890,000 SH DEFINED 3 750,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Pharmacopeia Inc. Common Stock 71713B104 $ 29,400 600,000 SH DEFINED 2 600,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Transkaryotic
Therapies Common Stock 89373510 $ 156,404 2,811,500 SH DEFINED 2 2,811,500 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
Trimeris Inc. Common Stock 896263100 $ 39,388 788,700 SH DEFINED 3 788,700 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
United
Therapeutics Common Stock 91307C102 $ 38,875 500,000 SH DEFINED 2 500,000 NONE NONE
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN
TOTALS $2,175,027
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
